The Stealth Shutdown of the US Agency for Healthcare Quality and Research (AHRQ) National Guideline Clearinghouse

DiscussionSo it seems that the report on clinical practice guidelines emphasized two issues highly relevant toHealth Care Renewal, the need fortransparency in guideline development, and the need to avoidconflicts of interest affecting the development process.Perhaps more because than despite that, as we noted above, by 2012 the IOM standards were largely ignored (as discussedhere).  We speculated that these standards may have discomfited many people.  They could have cost a lot of medical societies considerable commercial funding, and a lot of health care professionals on guideline panels considerable personal wealth.  These standards could probably also have cost a lot of companies whose products and services were addressed by guidelines to lose revenue.  Their implementation could have cost too many people who are financially benefiting from the status quo too much money.  And these people, that is, leaders of professional societies dependent on commercial outside funding, health care professionals and academic used to financial support from commercial interests, and health care corporations are good at making sure their interests are not ignored, even if their interests conflict with those of patients, the public, and well-intentioned health care professionals.The Trump regime has exhibited great coziness with those who lead large corporations, including health care corporations, and other such plutocrats (lookhere).  The Trump regime app...
Source: Health Care Renewal - Category: Health Management Tags: AHRQ anechoic effect Donald Trump evidence-based medicine guidelines Source Type: blogs